Literature DB >> 22075206

Intracellular metabolic pathways control immune tolerance.

Claudio Procaccini1, Mario Galgani, Veronica De Rosa, Giuseppe Matarese.   

Abstract

Disorders such as obesity and type 2 diabetes have been linked to immune dysfunction, raising the possibility that metabolic alterations can be induced by or be a consequence of alterations in immunological tolerance. Here, we describe how intracellular metabolic signalling pathways can 'sense' host energy/nutritional status, and in response, modulate regulatory T (Treg) cell function. In particular, we focus on mammalian target of rapamycin (mTOR) signalling, and how stimuli such as nutrients and leptin activate mTOR in an oscillatory manner to determine Treg cell proliferation status. We propose that metabolic changes such as nutritional deprivation or overload could dictate the characteristics of the Treg cell compartment and subsequent downstream immune reactions.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22075206     DOI: 10.1016/j.it.2011.09.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  30 in total

1.  Differential transcriptome of tolerogenic versus inflammatory dendritic cells points to modulated T1D genetic risk and enriched immune regulation.

Authors:  T Nikolic; N J C Woittiez; A van der Slik; S Laban; A Joosten; C Gysemans; C Mathieu; J J Zwaginga; B Koeleman; B O Roep
Journal:  Genes Immun       Date:  2017-08-10       Impact factor: 2.676

Review 2.  T-cell energy metabolism as a controller of cell fate in transplantation.

Authors:  Bhavana Priyadharshini; Laurence A Turka
Journal:  Curr Opin Organ Transplant       Date:  2015-02       Impact factor: 2.640

Review 3.  Stress and obesity as risk factors in cardiovascular diseases: a neuroimmune perspective.

Authors:  Flora Ippoliti; Nicoletta Canitano; Rita Businaro
Journal:  J Neuroimmune Pharmacol       Date:  2013-01-18       Impact factor: 4.147

Review 4.  Overnutrition, mTOR signaling, and cardiovascular diseases.

Authors:  Guanghong Jia; Annayya R Aroor; Luis A Martinez-Lemus; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-24       Impact factor: 3.619

5.  Treatment with a rho kinase inhibitor improves survival from graft-versus-host disease in mice after MHC-haploidentical hematopoietic cell transplantation.

Authors:  Sujatha Iyengar; Caixin Zhan; Jordan Lu; Robert Korngold; David H Schwartz
Journal:  Biol Blood Marrow Transplant       Date:  2014-05-02       Impact factor: 5.742

6.  Metabolic pressure and the breach of immunological self-tolerance.

Authors:  Veronica De Rosa; Antonio La Cava; Giuseppe Matarese
Journal:  Nat Immunol       Date:  2017-10-18       Impact factor: 25.606

Review 7.  Immunometabolism, pregnancy, and nutrition.

Authors:  Kristin Thiele; Lianghui Diao; Petra Clara Arck
Journal:  Semin Immunopathol       Date:  2017-10-25       Impact factor: 9.623

8.  Regulatory T cell proliferative potential is impaired in human autoimmune disease.

Authors:  Fortunata Carbone; Veronica De Rosa; Pietro B Carrieri; Silvana Montella; Dario Bruzzese; Antonio Porcellini; Claudio Procaccini; Antonio La Cava; Giuseppe Matarese
Journal:  Nat Med       Date:  2013-12-08       Impact factor: 53.440

Review 9.  Immunometabolism of regulatory T cells.

Authors:  Ryan Newton; Bhavana Priyadharshini; Laurence A Turka
Journal:  Nat Immunol       Date:  2016-05-19       Impact factor: 25.606

10.  Hunger-promoting hypothalamic neurons modulate effector and regulatory T-cell responses.

Authors:  Giuseppe Matarese; Claudio Procaccini; Ciro Menale; Jae Geun Kim; Jung Dae Kim; Sabrina Diano; Nadia Diano; Veronica De Rosa; Marcelo O Dietrich; Tamas L Horvath
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.